Company intelligence / Profile preview

NextGen Sciences

Ann Arbor, Michigan, USAclinicaltrialsarena.com ↗

Ownership: Private
Development stage: Other

Overview

Provided contract research services specializing in quantitative protein biomarker discovery and assay development using advanced mass spectrometry. Collaborated with academic institutions and industry partners. No proprietary clinical results as it was not a drug developer.

Therapeutic areas: CardiovascularNeurologyOncologyOther
Modalities: Protein biomarker assay development and qualificationMass spectrometry-based assaysMultiple reaction monitoring mass spectrometry platform
Industry: Contract Research Organization

Partnerships

Paragon BioservicesExpression PathologyHarvard Institute of Proteomics

Beyond the preview

Go deeper on NextGen Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NextGen Sciences.

Explore the full profile